These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 1712244
1. Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor. Yabkowitz R, Dixit VM. Cancer Res; 1991 Jul 15; 51(14):3648-56. PubMed ID: 1712244 [Abstract] [Full Text] [Related]
2. Human carcinoma cells express receptors for distinct domains of thrombospondin. Yabkowitz R, Dixit VM. Cancer Res; 1991 Mar 15; 51(6):1645-50. PubMed ID: 1705477 [Abstract] [Full Text] [Related]
3. Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction. Clezardin P, Serre CM, Trzeciak MC, Drouin J, Delmas PD. Cancer Res; 1991 May 15; 51(10):2621-7. PubMed ID: 1708697 [Abstract] [Full Text] [Related]
4. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma. Tuszynski GP, Nicosia RF. Lab Invest; 1994 Feb 15; 70(2):228-33. PubMed ID: 7511188 [Abstract] [Full Text] [Related]
5. Monocyte killing of human squamous epithelial cells: role for thrombospondin. Riser BL, Mitra R, Perry D, Dixit V, Varani J. Cancer Res; 1989 Nov 01; 49(21):6123-9. PubMed ID: 2676156 [Abstract] [Full Text] [Related]
6. Thrombospondin promotes both chemotaxis and haptotaxis in neutrophil-like HL-60 cells. Mansfield PJ, Suchard SJ. J Immunol; 1993 Mar 01; 150(5):1959-70. PubMed ID: 8436828 [Abstract] [Full Text] [Related]
7. Modulation of thrombospondin receptor expression during HL-60 cell differentiation. Suchard SJ, Mansfield PJ, Dixit VM. J Immunol; 1994 Jan 15; 152(2):877-88. PubMed ID: 7506739 [Abstract] [Full Text] [Related]
8. The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor. Taraboletti G, Belotti D, Borsotti P, Vergani V, Rusnati M, Presta M, Giavazzi R. Cell Growth Differ; 1997 Apr 15; 8(4):471-9. PubMed ID: 9101093 [Abstract] [Full Text] [Related]
9. Motility of human carcinoma cells in response to thrombospondin: relationship to metastatic potential and thrombospondin structural domains. Yabkowitz R, Mansfield PJ, Dixit VM, Suchard SJ. Cancer Res; 1993 Jan 15; 53(2):378-87. PubMed ID: 8417830 [Abstract] [Full Text] [Related]
10. Thrombospondin mediates migration and potentiates platelet-derived growth factor-dependent migration of calf pulmonary artery smooth muscle cells. Yabkowitz R, Mansfield PJ, Ryan US, Suchard SJ. J Cell Physiol; 1993 Oct 15; 157(1):24-32. PubMed ID: 8408239 [Abstract] [Full Text] [Related]
11. A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins alpha v beta 3, alpha v beta 5, and alpha v beta 6. Lehmann M, Rabenandrasana C, Tamura R, Lissitzky JC, Quaranta V, Pichon J, Marvaldi J. Cancer Res; 1994 Apr 15; 54(8):2102-7. PubMed ID: 7513610 [Abstract] [Full Text] [Related]
12. Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. Mansfield PJ, Suchard SJ. J Immunol; 1994 Nov 01; 153(9):4219-29. PubMed ID: 7930624 [Abstract] [Full Text] [Related]
13. Thrombospondin induces glomerular mesangial cell adhesion and migration. Taraboletti G, Morigi M, Figliuzzi M, Giavazzi R, Zoja C, Remuzzi G. Lab Invest; 1992 Nov 01; 67(5):566-71. PubMed ID: 1434535 [Abstract] [Full Text] [Related]
14. Analysis of integrin receptors for laminin and type IV collagen on metastatic B16 melanoma cells. Ramos DM, Berston ED, Kramer RH. Cancer Res; 1990 Feb 01; 50(3):728-34. PubMed ID: 2153445 [Abstract] [Full Text] [Related]
15. Activation of human neutrophils increases thrombospondin receptor expression. Suchard SJ, Boxer LA, Dixit VM. J Immunol; 1991 Jul 15; 147(2):651-9. PubMed ID: 1712815 [Abstract] [Full Text] [Related]
16. Cell-associated proteoheparan sulfate mediates binding and uptake of thrombospondin in cultured porcine vascular endothelial cells. Schön P, Vischer P, Völker W, Schmidt A, Faber V. Eur J Cell Biol; 1992 Dec 15; 59(2):329-39. PubMed ID: 1493798 [Abstract] [Full Text] [Related]
17. Melanoma cell adhesion to basement membrane mediated by integrin-related complexes. Kramer RH, McDonald KA, Crowley E, Ramos DM, Damsky CH. Cancer Res; 1989 Jan 15; 49(2):393-402. PubMed ID: 2535959 [Abstract] [Full Text] [Related]
18. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1. Merle B, Malaval L, Lawler J, Delmas P, Clezardin P. J Cell Biochem; 1997 Oct 01; 67(1):75-83. PubMed ID: 9328841 [Abstract] [Full Text] [Related]
19. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells. Shahan TA, Ziaie Z, Pasco S, Fawzi A, Bellon G, Monboisse JC, Kefalides NA. Cancer Res; 1999 Sep 15; 59(18):4584-90. PubMed ID: 10493512 [Abstract] [Full Text] [Related]
20. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein. Simantov R, Febbraio M, Silverstein RL. Matrix Biol; 2005 Feb 15; 24(1):27-34. PubMed ID: 15748999 [Abstract] [Full Text] [Related] Page: [Next] [New Search]